Skip to main content
. 2022 Jun 22;145(11):4080–4096. doi: 10.1093/brain/awac217
I. Patient shows gradually progressive deterioration by history and/or testing
II. Clinical diagnosis of sbvFTD:
Patient must have two out of the core features A–C and two out of the supportive features D–F:
Core features:
A. Loss of empathy (difficulty understanding emotions)
B. Difficulty naming and identifying known people
C. Complex compulsions or rigid thought process
Supportive features:
D. Object naming difficulties
E. Spared visuospatial functions including preserved perceptual matching and drawing reproduction
F. Spared motor speech and phonology
III. Imaging-supported sbvFTD:
All the following must be present:
A. Meets criteria for sbvFTD and
B. Imaging results consistent with sbvFTD: Laterality is right-sided in right-handed but could be left-sided in non-right-handed individuals.
 (i) Anterior temporal lobe volume loss and relative sparing of the frontal cortex on MRI or CT; or
 (ii) Anterior temporal lobe hypometabolism and relative sparing of the frontal cortex on FDG-PET
IV. SbvFTD with definite pathology
All the following must be present:
A. Clinical diagnosis of sbvFTD
B. Histopathological or genetic evidence:
 (i) Histopathology of a specific neurodegenerative pathology (e.g. FTLD-TDP, FTLD-tau, other); or
 (ii) Presence of known pathogenic mutation